(Reuters)—The U.S. Food and Drug Administration on Thursday listed drugmakers, including Celgene Corp, Johnson & Johnson, Gilead Sciences and Novartis AG, who the regulator says are potentially blocking access to samples of their drugs to delay generic competition. Generic drugmakers may not be able to develop alternatives without access to samples of branded products they…
5 Ways to Unlock the Power of Consultation
Think back to your time as a trainee. Do you remember an interaction with a consultant in which you learned something, felt your opinion was heard, were empowered to collaborate with the consulting team and knew you were providing outstanding care? We suspect a number of examples come to mind, regardless of the amount of…
Tips & Tools for Dealing with Bad Patient Outcomes
Bad things happen to good rheumatologists—and to their patients—and can have profound personal and professional consequences for the doctor. Sometimes recommended treatments can have predictable, but devastating, side effects. Even if the rheumatologist does everything right according to evidence-based best practice, patients can still have bad outcomes, even die—with resulting feelings of sadness, anger, guilt…
Rheumatology Can Use MACRA to Drive Healthcare Improvements
We have entered the second year of the Medicare Access and CHIP (Children’s Health Insurance Program) Reauthorization Act (MACRA) of 2015. It’s no secret that the costs of medical care—17.1% of the U.S. gross national product compared with 9.8% in Great Britain, 10.7% in Canada and 11.6% in France—have become an overwhelming driver for change….
Opioid Refusals: How to Deal with the Angry or Hostile Patient
In July 2017, Todd A. Graham, MD, a practicing orthopedic surgeon in South Bend, Ind., was fatally shot after getting into a heated dispute with a patient and her husband over a requested opioid prescription.1 The murder of Dr. Graham is a tragic example of the potential dangers of physician-patient disagreements. Rheumatology patients often endure…
Rheumatologists Discuss Opportunities, Benefits Found in Retirement
Retirement is not always the closing chapter of a long career. For some rheumatologists, it’s the start of new, fulfilling storylines. “I never thought I wouldn’t practice medicine until I was physically unable to do it anymore,” says Harry Gewanter, MD, who retired from his Richmond, Va., pediatric rheumatology practice two years ago. Dr. Gewanter…
The ACR’s COIN Department Connects Providers with Communities
Last month I expressed my thoughts on the valuable and varied opportunities the ACR offers for professional and personal growth. Such engagement not only provides an opportunity to connect with your rheumatology colleagues, but also to have a positive impact on patients, supporters and all consumers of healthcare. ACR and ARHP members from every aspect…
ACR Program Encourages Innovation & Opportunity
With a steadily diversifying U.S. population, the professional and societal consequences of health disparities continue to grow. Rheumatologists may need to innovate to prevent these disparities for their patients. A new ACR program will focus on member-led projects that reduce health racial and ethnic disparities for patients with rheumatic disease…
At the Table: ACR Meets with MedPAC
The Medicare Payment Advisory Commission (MedPAC) makes recommendations to Congress on Medicare policy including physician payments and patient access issues. These recommendations can directly impact rheumatology care coverage and rheumatologist reimbursement. Representatives of the ACR and partners recently met with new MedPAC Executive Director James E. Mathews, PhD, to discuss appropriate recognition of rheumatology care…
Clinical Remission Should Be Target of JIA Treatment: Task Force
NEW YORK (Reuters Health)—An international task force says patients with juvenile idiopathic arthritis (JIA) should be treated to a target of clinical remission, among other new recommendations. “The Task Force is convinced that transferring (the recommendations) into clinical practice will significantly improve the outcomes in patients with JIA,” Dr. Angelo Ravelli of the Istituto G….
- « Previous Page
- 1
- …
- 49
- 50
- 51
- 52
- 53
- …
- 151
- Next Page »